The unassuming mushroom, a remarkable member of the fungi kingdom, possesses an abundance of potential. Prior investigations have indicated that mushrooms may mitigate the risk of depression, foster the growth of brain cells, and offer protective effects against cancer. Recent research further suggests that these fungi might also confer a degree of protection against influenza.
A team of researchers from McGill University in Canada discovered that the beta-glucan fibers present in various mushroom species can function as a defensive barrier against the flu. Their findings revealed that these fibers limit lung inflammation in mice subjected to viral infection post-administration of beta-glucan.
Furthermore, mice treated with these fibers exhibited enhanced pulmonary function and a reduced likelihood of severe illness and mortality when infected with the flu virus. Although human clinical trials are necessary for further insights, these preliminary results present a promising avenue for ongoing research.
“Beta-glucan, located within the cell walls of all fungi, including those inhabiting our bodies as part of the human microbiome, has intriguing implications,” stated Maziar Divangahi, an immunologist at McGill University.
“It is intriguing to consider that variations in the levels and types of fungi present in an individual could influence their immune response to infections, potentially mediated by beta-glucan.”
Though beta-glucan is well-established for its ability to enhance immunity, this research sought to explore its potential for disease tolerance. This concept encompasses the idea of diminishing the effects of viral infections on the body, rather than merely eradicating the pathogens as traditional antiviral therapies do.
Notably, beta-glucan appears to reprogram immune cells to better manage influenza infections. Mice receiving treatment exhibited an increased population of immune cells known as neutrophils, which operated with greater regulation than usual.
The researchers emphasized that this reprogramming was essential, as it mitigated the risk of neutrophils becoming hyperactive in their fight against infection—a common precursor to lung inflammation and subsequent complications, such as pneumonia, following flu infections.
“While neutrophils are typically associated with inflammation, beta-glucan has the remarkable ability to recalibrate their function to reduce it,” noted Kim Tran, another McGill immunologist.
Additionally, the modified neutrophils persisted for several weeks in the treated mice, suggesting that a therapeutic approach utilizing beta-glucan could provide enduring protection, although further research is essential to fully comprehend its implications.
While the advantages of disease tolerance are well-recognized—and crucial for saving lives—our understanding of the underlying mechanisms remains limited. This investigation provides valuable insights and may pave the way for future applications in addressing similar respiratory ailments.
“It is striking to observe how beta-glucan can reprogram select immune cells, such as neutrophils, to effectively manage excessive inflammation in the lungs,” remarked Nargis Khan, an immunologist now affiliated with the University of Calgary in Canada.
This groundbreaking research has been published in Nature Immunology.
Vocabulary List:
- Mitigate /ˈmɪtɪˌɡeɪt/ (verb): To make something less severe serious or painful.
- Inflammation /ɪnˌflæməˈteɪʃən/ (noun): A localized physical condition characterized by redness swelling heat and pain often as a reaction to injury or infection.
- Neutrophils /ˈnjuːtrəˌfɪlz/ (noun): A type of white blood cell that helps the body fight infection.
- Reprogramming /ˌriːˈproʊɡræmɪŋ/ (verb): The act of changing the function or characteristics of cells.
- Tolerance /ˈtɒlərəns/ (noun): The ability to endure adverse conditions or the presence of pathogens without severe reaction.
- Enduring /ɪnˈdʊrɪŋ/ (adjective): Lasting over a period of time; durable.
How much do you know?
